This exclusive webinar will explore the following considerations:
- The epidemiology of pain and its impact upon quality-of-life
- Patho-physiology of pain
- Heritability and genetics of pain
- Pharmacogenetics of pain receptors, signaling, and metabolism of pain medications
- Applying gene testing in analgesic clinical drug development
There may be many networking opportunities at the Personalized Medicine: Genetic Testing for Predicting Opioid Response. Find out more in the event details below.
|Conference/Event Dates:||03/22/2016 - 03/22/2016|
|Primary Industry:||Clinical Pharmacology|
|Other Industries:||Clinical Pharmacology, Genetics, Professional Healthcare|
|Audience:||"C-Level" Executives - CSO/CMO
Drug Developers in the CNS/Pain/Addiction Therapy fields
Heads of Global Clinical Development
Patient Recruitment and Retention professionals
Senior Physicians/ Prescribers of opioid medications
Clinical Trial Planning and Optimization
|Booth Size||Booth Cost||Available Amenities|
|Marketing Vehicles Allowed:||n/a|
|Other Booth Sizes Available: n/a|
How do I show up here?
Add a note here, it is only visible by you.